ScholarIQanswers from OpenAlex & ORCID
Thomas M. Pisansky
ResearcherPublications, citations & collaboration network
Thomas M. Pisansky is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Thomas M. Pisansky have?
ScholarIQindexed works
Thomas M. Pisansky has 336 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Thomas M. Pisansky have?
ScholarIQcitation count
Thomas M. Pisansky has 21,965 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Thomas M. Pisansky?
ScholarIQh-index
Thomas M. Pisansky has an h-index of 64 in OpenAlex.
What is the i10-index of Thomas M. Pisansky?
ScholarIQi10-index
Thomas M. Pisansky has an i10-index of 160 in OpenAlex.
What is the OpenAlex record for Thomas M. Pisansky?
ScholarIQopenalex
The OpenAlex for Thomas M. Pisansky is on the source record.
What are the most-cited papers on Thomas M. Pisansky?
ScholarIQmost cited works
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark
INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy
Bruce D. Minsky, Thomas F. Pajak, Robert J. Ginsberg, Thomas M. Pisansky, James A. Martenson, Ritsuko Komaki, Gordon Okawara, Seth A. Rosenthal, David P. Kelsen
Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
Robert T. Dess, Holly Hartman, Brandon A. Mahal, Payal Soni, Will Jackson, Matthew R. Cooperberg, Christopher L. Amling, William J. Aronson, Christopher J. Kane, Martha K. Terris, Zachary S. Zumsteg, Santino Butler, Joseph R. Osborne, Todd M. Morgan, Rohit Mehra, Simpa S. Salami, Amar U. Kishan, Chenyang Wang, Edward M. Schaeffer, Mack Roach, Thomas M. Pisansky, William U. Shipley, Stephen J. Freedland, Howard M. Sandler, Susan Halabi, Felix Y. Feng, James J. Dignam, Paul L. Nguyen, Matthew J. Schipper, Daniel E. Spratt
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
Andre Esteva, Jean Feng, Douwe van der Wal, Shih-Cheng Huang, Jeffry Simko, Sandy DeVries, Emmalyn Chen, Edward M. Schaeffer, Todd M. Morgan, Yilun Sun, Amirata Ghorbani, Nikhil Naik, Dhruv Nathawani, Richard Socher, Jeff M. Michalski, Mack Roach, Thomas M. Pisansky, Jedidiah M. Monson, Farah Naz, James A. Wallace, Michelle Ferguson, Jean-Paul Bahary, James Zou, Matthew P. Lungren, Serena Yeung, Ashley E. Ross, Michael Jonathan Kucharczyk, Luís Souhami, Leslie Ballas, Christopher A. Peters, Sandy Liu, Alexander G. Balogh, Pamela Randolph-Jackson, David L. Schwartz, M.R. Girvigian, Naoyuki G. Saito, Adam Raben, Rachel Rabinovitch, Khalil Katato, Howard M. Sandler, Phuoc T. Tran, Daniel E. Spratt, Stephanie L. Pugh, Felix Y. Feng, Osama Mohamad